Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nivolumab and Ipilimumab in Advanced Transitional Cell Carcinoma
NCT03219775Phase 2Unknown
- Sponsor
- AIO-Studien
- Start
- Jul 2017
- Primary completion
- Sep 2021
- Countries
- 2
01
Overview
A Phase 2 trial of nivolumab in transitional cell carcinoma (TCC), sponsored by AIO-Studien. Status: unknown.
02
Drugs
03
Conditions
transitional cell carcinoma (TCC)
Beyond the preview
Go deeper on NCT03219775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03219775.